Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Veri Medtech Holdings's Enterprise Value is $39.09 Mil.
Veri Medtech Holdings does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2021. Therefore, GuruFocus does not calculate Veri Medtech Holdings's EV-to-EBIT at this moment.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Veri Medtech Holdings's Enterprise Value is $39.09 Mil.
Veri Medtech Holdings does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Dec. 2021. Therefore, GuruFocus does not calculate Veri Medtech Holdings's EV-to-EBITDA at this moment.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Veri Medtech Holdings's Enterprise Value is $39.09 Mil.
Veri Medtech Holdings does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in Dec. 2021. Therefore, GuruFocus does not calculate Veri Medtech Holdings's EV-to-Revenue at this moment.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Veri Medtech Holdings's Enterprise Value is $39.09 Mil.
Veri Medtech Holdings does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2021. Therefore, GuruFocus does not calculate Veri Medtech Holdings's EV-to-FCF at this moment.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Veri Medtech Holdings (OTCPK:VRHI) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
Veri Medtech Holdings Enterprise Value Related Terms
Veri Medtech Holdings Enterprise Value Historical Data
* Premium members only.
The historical data trend for Veri Medtech Holdings's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veri Medtech Holdings Enterprise Value Chart
Veri Medtech Holdings Annual Data
Trend
Dec21
Enterprise Value
0.00
Veri Medtech Holdings Semi-Annual Data
Dec21
Enterprise Value
0.00
VRHI vs MMVVF, BLMZ, MVNC: Enterprise Value Comparison
For the Health Information Services subindustry, Veri Medtech Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veri Medtech Holdings Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veri Medtech Holdings's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Veri Medtech Holdings's Enterprise Value falls into.
Veri Medtech Holdings Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Veri Medtech Holdings's Enterprise Value for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veri Medtech Holdings (VRHI) has a Enterprise Value of $39.09 Mil as of Jun. 28, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Veri Medtech Holdings and its competitors.
Is Veri Medtech Holdings' Enterprise Value too high?
Veri Medtech Holdings' current Enterprise Value is $39.09 Mil. Overall, Veri Medtech Holdings has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Veri Medtech Holdings' Enterprise Value compare to MMVVF and BLMZ?
Veri Medtech Holdings' Enterprise Value of $39.09 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Veri Medtech Holdings and its competitors. Veri Medtech Holdings's current Enterprise Value is $39.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veri Medtech Holdings stock overvalued right now?
Veri Medtech Holdings (VRHI) has a current Enterprise Value of $39.09 Mil. The current Enterprise Value is $39.09 Mil. Veri Medtech Holdings' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Veri Medtech Holdings (VRHI), the current Enterprise Value is $39.09 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Veri Medtech Holdings Inc is a healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With an integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models.
35GF Score
Get the complete analysis for VRHI
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VRHI has been successfully added to your 